AstraZeneca PLC (NYSE:AZN) investors received a reassuring earnings report at a sensitive point in the company’s growth story ...
15h
Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery? (Ready for Vardah)
Novo Nordisk A/S (NYSE:NVO) has entered a strategic partnership with Amazon Web Services to accelerate drug discovery and ...
Johnson & Johnson (NYSE:JNJ) has proposed a whopping $5.5 billion settlement to resolve tens of thousands of lawsuits that ...
The timing of Zoetis Inc.’s (NYSE:ZTS) latest regulatory win is particularly relevant for shareholders. Just one week after ...
Pfizer Inc. (NYSE:PFE) is beginning to show signs of steadier growth following the sharp decline in its pandemic-related ...
Gilead Sciences, Inc. (NASDAQ:GILD) delivered strong fiscal Q2 2026 results, with total revenue rising 10% year over year to ...
AbbVie Inc. (NYSE:ABBV) spent years preparing investors for the decline of Humira, once one of the best-selling medicines in ...
That distinction is significant for investors because Gilead’s (NASDAQ:GILD) existing business appears healthy enough to ...
The Walt Disney Company (NYSE:DIS) has secured a multi-year agreement to stream the all-electric Formula E World Championship ...
Healthcare investors are often faced with a choice between companies that generate steady growth across diversified ...
Both companies delivered strong quarterly results, yet the market reacted very differently. Abbott (NYSE:ABT) raised its ...
Patent expirations are forcing Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) to prove that their newer medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results